These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37986945)

  • 21. Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy.
    Iyengar SK; Fox KA; Schachere M; Manzoor F; Slaughter ME; Covic AM; Orloff SM; Hayden PS; Olson JM; Schelling JR; Sedor JR
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S195-201. PubMed ID: 12819328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein Tyrosine Phosphatases: Mechanisms in Cancer.
    Sivaganesh V; Sivaganesh V; Scanlon C; Iskander A; Maher S; Lê T; Peethambaran B
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domain-containing tyrosine phosphatases (SHPs).
    Irandoust M; van den Berg TK; Kaspers GJ; Cloos J
    Anticancer Agents Med Chem; 2009 Feb; 9(2):212-20. PubMed ID: 19199865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study.
    Ji X; Tang J; Halberg R; Busam D; Ferriera S; Peña MM; Venkataramu C; Yeatman TJ; Zhao S
    BMC Cancer; 2010 Aug; 10():426. PubMed ID: 20707908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of TCR Signaling by Tyrosine Phosphatases: From Autoimmunity to Immunotherapy.
    Castro-Sanchez P; Teagle AR; Prade S; Zamoyska R
    Front Cell Dev Biol; 2020; 8():608747. PubMed ID: 33425916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DUSP3/VHR: A Druggable Dual Phosphatase for Human Diseases.
    Monteiro LF; Ferruzo PYM; Russo LC; Farias JO; Forti FL
    Rev Physiol Biochem Pharmacol; 2019; 176():1-35. PubMed ID: 30069819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.
    Kohno T; Otsuka A; Girard L; Sato M; Iwakawa R; Ogiwara H; Sanchez-Cespedes M; Minna JD; Yokota J
    Genes Chromosomes Cancer; 2010 Apr; 49(4):342-52. PubMed ID: 20073072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia.
    Boni C; Sorio C
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing for colon neoplasia susceptibility variants at the human COX2 locus.
    Wiesner GL; Platzer P; Buxbaum S; Lewis S; MacMillen M; Olechnowicz J; Willis J; Chakravarti A; Elston RC; Markowitz SD
    J Natl Cancer Inst; 2001 Apr; 93(8):635-9. PubMed ID: 11309440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil.
    Blackwell JM
    Int J Parasitol; 1998 Jan; 28(1):21-8. PubMed ID: 9504332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A genome-wide survey of human tyrosine phosphatases.
    Bhaduri A; Sowdhamini R
    Protein Eng; 2003 Dec; 16(12):881-8. PubMed ID: 14983067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemia.
    Li J; Pang Q
    Antioxid Redox Signal; 2014 May; 20(14):2290-301. PubMed ID: 24206276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The serine, threonine, and/or tyrosine-specific protein kinases and protein phosphatases of prokaryotic organisms: a family portrait.
    Shi L; Potts M; Kennelly PJ
    FEMS Microbiol Rev; 1998 Oct; 22(4):229-53. PubMed ID: 9862122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic structure and alternative splicing of murine R2B receptor protein tyrosine phosphatases (PTPkappa, mu, rho and PCP-2).
    Besco J; Popesco MC; Davuluri RV; Frostholm A; Rotter A
    BMC Genomics; 2004 Feb; 5(1):14. PubMed ID: 15040814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
    Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
    Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocyte common antigen-related phosphatase (LRP) gene structure: conservation of the genomic organization of transmembrane protein tyrosine phosphatases.
    Wong EC; Mullersman JE; Thomas ML
    Genomics; 1993 Jul; 17(1):33-8. PubMed ID: 8406469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein phosphorylation on tyrosine in bacteria.
    Cozzone AJ; Grangeasse C; Doublet P; Duclos B
    Arch Microbiol; 2004 Mar; 181(3):171-81. PubMed ID: 14745484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic resolution of susceptibility to cancer--new perspectives.
    Demant P
    Semin Cancer Biol; 1992 Jun; 3(3):159-66. PubMed ID: 1511158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states.
    Zhang YY; Mei ZQ; Wu JW; Wang ZX
    J Biol Chem; 2008 Sep; 283(39):26591-601. PubMed ID: 18669639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 10 years of mouse cancer modifier loci: human relevance.
    Dragani TA
    Cancer Res; 2003 Jun; 63(12):3011-8. PubMed ID: 12810618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.